Germline BRCA1 and BRCA2 mutations in Greek breast/ovarian cancer families - 5382insC is the most frequent mutation observed

A. Ladopoulou, A. Ladopoulou, C. Kroupis, C. Kroupis, I. Konstantopoulou, I. Konstantopoulou, L. Ioannidou-Mouzaka, L. Ioannidou-Mouzaka, Andrew Craig Schofield, Andrew Craig Schofield, A. Pantazidis, A. Pantazidis, S. Armaou, S. Armaou, I. Tsiagas, I. Tsiagas, E. Lianidou, E. Lianidou, E. Efstathiou, E. EfstathiouC. Tsionou, C. Tsionou, C. Panopoulos, C. Panopoulos, M. Michalatos, M. Michalatos, G. Nasioulas, G. Nasioulas, D. Skarlos, D. Skarlos, Neva Elizabeth Haites, Neva Elizabeth Haites, G. Fountzilas, G. Fountzilas, N. Pandis, N. Pandis, D. Yannoukakos, D. Yannoukakos

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

BRCA1 and BRCA2 genes were screened for loss-of-function mutations in a series of 85 patients having at least one first- or second-degree relative affected by breast and/or ovarian cancer. All BRCA1 exons and BRCA2 exons 10 and 11 were screened with a combination of methods including SSCP, PTT and direct sequencing. We have found disease-associated mutations in 14 families (16.5%), eleven in BRCA1 and three in BRCA2. The known founder mutation 5382insC of BRCA1 was identified in seven unrelated families. The other mutations identified include the non-sense R1751X, the splice junction variant 5586G > A of BRCA1 and three frameshifts, 2024de15, 3034del4, and 6631del5, of BRCA2. Nine out of these 14 families had a family history of three or more breast/ovarian cancer cases. A large number of polymorphic or unclassified variants is also reported. Combined with our previously published data 5382insC was found in nine out of 20 families (45%), suggesting that this mutation may represent a common founder mutation in the Greek population. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.

Original languageEnglish
Pages (from-to)61-70
Number of pages9
JournalCancer Letters
Volume185
DOIs
Publication statusPublished - 2002

Keywords

  • BRCA1
  • BRCA2
  • Greece
  • familial
  • breast ovarian cancer
  • BREAST-CANCER
  • OVARIAN-CANCER
  • HEREDITARY BREAST
  • GENES
  • RISK

Cite this

Ladopoulou, A., Ladopoulou, A., Kroupis, C., Kroupis, C., Konstantopoulou, I., Konstantopoulou, I., ... Yannoukakos, D. (2002). Germline BRCA1 and BRCA2 mutations in Greek breast/ovarian cancer families - 5382insC is the most frequent mutation observed. Cancer Letters, 185, 61-70. https://doi.org/10.1016/S0304-3835(01)00845-X

Germline BRCA1 and BRCA2 mutations in Greek breast/ovarian cancer families - 5382insC is the most frequent mutation observed. / Ladopoulou, A.; Ladopoulou, A.; Kroupis, C.; Kroupis, C.; Konstantopoulou, I.; Konstantopoulou, I.; Ioannidou-Mouzaka, L.; Ioannidou-Mouzaka, L.; Schofield, Andrew Craig; Schofield, Andrew Craig; Pantazidis, A.; Pantazidis, A.; Armaou, S.; Armaou, S.; Tsiagas, I.; Tsiagas, I.; Lianidou, E.; Lianidou, E.; Efstathiou, E.; Efstathiou, E.; Tsionou, C.; Tsionou, C.; Panopoulos, C.; Panopoulos, C.; Michalatos, M.; Michalatos, M.; Nasioulas, G.; Nasioulas, G.; Skarlos, D.; Skarlos, D.; Haites, Neva Elizabeth; Haites, Neva Elizabeth; Fountzilas, G.; Fountzilas, G.; Pandis, N.; Pandis, N.; Yannoukakos, D.; Yannoukakos, D.

In: Cancer Letters, Vol. 185, 2002, p. 61-70.

Research output: Contribution to journalArticle

Ladopoulou, A, Ladopoulou, A, Kroupis, C, Kroupis, C, Konstantopoulou, I, Konstantopoulou, I, Ioannidou-Mouzaka, L, Ioannidou-Mouzaka, L, Schofield, AC, Schofield, AC, Pantazidis, A, Pantazidis, A, Armaou, S, Armaou, S, Tsiagas, I, Tsiagas, I, Lianidou, E, Lianidou, E, Efstathiou, E, Efstathiou, E, Tsionou, C, Tsionou, C, Panopoulos, C, Panopoulos, C, Michalatos, M, Michalatos, M, Nasioulas, G, Nasioulas, G, Skarlos, D, Skarlos, D, Haites, NE, Haites, NE, Fountzilas, G, Fountzilas, G, Pandis, N, Pandis, N, Yannoukakos, D & Yannoukakos, D 2002, 'Germline BRCA1 and BRCA2 mutations in Greek breast/ovarian cancer families - 5382insC is the most frequent mutation observed', Cancer Letters, vol. 185, pp. 61-70. https://doi.org/10.1016/S0304-3835(01)00845-X
Ladopoulou, A. ; Ladopoulou, A. ; Kroupis, C. ; Kroupis, C. ; Konstantopoulou, I. ; Konstantopoulou, I. ; Ioannidou-Mouzaka, L. ; Ioannidou-Mouzaka, L. ; Schofield, Andrew Craig ; Schofield, Andrew Craig ; Pantazidis, A. ; Pantazidis, A. ; Armaou, S. ; Armaou, S. ; Tsiagas, I. ; Tsiagas, I. ; Lianidou, E. ; Lianidou, E. ; Efstathiou, E. ; Efstathiou, E. ; Tsionou, C. ; Tsionou, C. ; Panopoulos, C. ; Panopoulos, C. ; Michalatos, M. ; Michalatos, M. ; Nasioulas, G. ; Nasioulas, G. ; Skarlos, D. ; Skarlos, D. ; Haites, Neva Elizabeth ; Haites, Neva Elizabeth ; Fountzilas, G. ; Fountzilas, G. ; Pandis, N. ; Pandis, N. ; Yannoukakos, D. ; Yannoukakos, D. / Germline BRCA1 and BRCA2 mutations in Greek breast/ovarian cancer families - 5382insC is the most frequent mutation observed. In: Cancer Letters. 2002 ; Vol. 185. pp. 61-70.
@article{027ccc0eef5d49e2bb8e7202faae8640,
title = "Germline BRCA1 and BRCA2 mutations in Greek breast/ovarian cancer families - 5382insC is the most frequent mutation observed",
abstract = "BRCA1 and BRCA2 genes were screened for loss-of-function mutations in a series of 85 patients having at least one first- or second-degree relative affected by breast and/or ovarian cancer. All BRCA1 exons and BRCA2 exons 10 and 11 were screened with a combination of methods including SSCP, PTT and direct sequencing. We have found disease-associated mutations in 14 families (16.5{\%}), eleven in BRCA1 and three in BRCA2. The known founder mutation 5382insC of BRCA1 was identified in seven unrelated families. The other mutations identified include the non-sense R1751X, the splice junction variant 5586G > A of BRCA1 and three frameshifts, 2024de15, 3034del4, and 6631del5, of BRCA2. Nine out of these 14 families had a family history of three or more breast/ovarian cancer cases. A large number of polymorphic or unclassified variants is also reported. Combined with our previously published data 5382insC was found in nine out of 20 families (45{\%}), suggesting that this mutation may represent a common founder mutation in the Greek population. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.",
keywords = "BRCA1, BRCA2, Greece, familial, breast ovarian cancer, BREAST-CANCER, OVARIAN-CANCER, HEREDITARY BREAST, GENES, RISK",
author = "A. Ladopoulou and A. Ladopoulou and C. Kroupis and C. Kroupis and I. Konstantopoulou and I. Konstantopoulou and L. Ioannidou-Mouzaka and L. Ioannidou-Mouzaka and Schofield, {Andrew Craig} and Schofield, {Andrew Craig} and A. Pantazidis and A. Pantazidis and S. Armaou and S. Armaou and I. Tsiagas and I. Tsiagas and E. Lianidou and E. Lianidou and E. Efstathiou and E. Efstathiou and C. Tsionou and C. Tsionou and C. Panopoulos and C. Panopoulos and M. Michalatos and M. Michalatos and G. Nasioulas and G. Nasioulas and D. Skarlos and D. Skarlos and Haites, {Neva Elizabeth} and Haites, {Neva Elizabeth} and G. Fountzilas and G. Fountzilas and N. Pandis and N. Pandis and D. Yannoukakos and D. Yannoukakos",
year = "2002",
doi = "10.1016/S0304-3835(01)00845-X",
language = "English",
volume = "185",
pages = "61--70",
journal = "Cancer Letters",
issn = "0304-3835",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Germline BRCA1 and BRCA2 mutations in Greek breast/ovarian cancer families - 5382insC is the most frequent mutation observed

AU - Ladopoulou, A.

AU - Ladopoulou, A.

AU - Kroupis, C.

AU - Kroupis, C.

AU - Konstantopoulou, I.

AU - Konstantopoulou, I.

AU - Ioannidou-Mouzaka, L.

AU - Ioannidou-Mouzaka, L.

AU - Schofield, Andrew Craig

AU - Schofield, Andrew Craig

AU - Pantazidis, A.

AU - Pantazidis, A.

AU - Armaou, S.

AU - Armaou, S.

AU - Tsiagas, I.

AU - Tsiagas, I.

AU - Lianidou, E.

AU - Lianidou, E.

AU - Efstathiou, E.

AU - Efstathiou, E.

AU - Tsionou, C.

AU - Tsionou, C.

AU - Panopoulos, C.

AU - Panopoulos, C.

AU - Michalatos, M.

AU - Michalatos, M.

AU - Nasioulas, G.

AU - Nasioulas, G.

AU - Skarlos, D.

AU - Skarlos, D.

AU - Haites, Neva Elizabeth

AU - Haites, Neva Elizabeth

AU - Fountzilas, G.

AU - Fountzilas, G.

AU - Pandis, N.

AU - Pandis, N.

AU - Yannoukakos, D.

AU - Yannoukakos, D.

PY - 2002

Y1 - 2002

N2 - BRCA1 and BRCA2 genes were screened for loss-of-function mutations in a series of 85 patients having at least one first- or second-degree relative affected by breast and/or ovarian cancer. All BRCA1 exons and BRCA2 exons 10 and 11 were screened with a combination of methods including SSCP, PTT and direct sequencing. We have found disease-associated mutations in 14 families (16.5%), eleven in BRCA1 and three in BRCA2. The known founder mutation 5382insC of BRCA1 was identified in seven unrelated families. The other mutations identified include the non-sense R1751X, the splice junction variant 5586G > A of BRCA1 and three frameshifts, 2024de15, 3034del4, and 6631del5, of BRCA2. Nine out of these 14 families had a family history of three or more breast/ovarian cancer cases. A large number of polymorphic or unclassified variants is also reported. Combined with our previously published data 5382insC was found in nine out of 20 families (45%), suggesting that this mutation may represent a common founder mutation in the Greek population. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.

AB - BRCA1 and BRCA2 genes were screened for loss-of-function mutations in a series of 85 patients having at least one first- or second-degree relative affected by breast and/or ovarian cancer. All BRCA1 exons and BRCA2 exons 10 and 11 were screened with a combination of methods including SSCP, PTT and direct sequencing. We have found disease-associated mutations in 14 families (16.5%), eleven in BRCA1 and three in BRCA2. The known founder mutation 5382insC of BRCA1 was identified in seven unrelated families. The other mutations identified include the non-sense R1751X, the splice junction variant 5586G > A of BRCA1 and three frameshifts, 2024de15, 3034del4, and 6631del5, of BRCA2. Nine out of these 14 families had a family history of three or more breast/ovarian cancer cases. A large number of polymorphic or unclassified variants is also reported. Combined with our previously published data 5382insC was found in nine out of 20 families (45%), suggesting that this mutation may represent a common founder mutation in the Greek population. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.

KW - BRCA1

KW - BRCA2

KW - Greece

KW - familial

KW - breast ovarian cancer

KW - BREAST-CANCER

KW - OVARIAN-CANCER

KW - HEREDITARY BREAST

KW - GENES

KW - RISK

U2 - 10.1016/S0304-3835(01)00845-X

DO - 10.1016/S0304-3835(01)00845-X

M3 - Article

VL - 185

SP - 61

EP - 70

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

ER -